Cited by 39Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Inhibition-Based Biomarkers for Autism Spectrum Disorder

Open access
Levin, April R., Nelson, Charles A.·2015·Neurotherapeutics

Abstract

Autism spectrum disorder (ASD) is a behaviorally defined and heterogeneous disorder. Biomarkers for ASD offer the opportunity to improve prediction, diagnosis, stratification by severity and subtype, monitoring over time and in response to interventions, and overall understanding of the underlying biology of this disorder. A variety of potential biomarkers, from the level of genes and proteins to network-level interactions, is currently being examined. Many of these biomarkers relate to inhibition, which is of particular interest because in many cases ASD is thought to be a disorder of imbalance between excitation and inhibition. Abnormalities in inhibition at the cellular level lead to emergent properties in networks of neurons. These properties take into account a more complete genetic and cellular background than findings at the level of individual genes or cells, and are able to be measured in live humans, offering additional potential as diagnostic biomarkers and predictors of behaviors. In this review we provide examples of how altered inhibition may inform the search for ASD biomarkers at multiple levels, from genes to cells to networks.

Integrity signals

Registry

Crossref · 10.1007/s13311-015-0350-1

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Levin, A. R., & Nelson, C. A.
Affiliations
Boston Children's Hospital (US)
Corresponding author
Levin, April R.
Venue
Neurotherapeutics
Publisher
Elsevier BV
Published
2015-07
Volume
12
Issue
3
Pages
546-552
ISSN
1878-7479 (ISSN-L)
OpenAlex
W2025757345
Cited by
39
References
16
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 2 · 2016: 5 · 2015: 1
FWCI
0.27
Type
journal article
Language
en
Open access
Locations
  • Neurotherapeutics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Simons Foundation
  • American Brain Foundation
  • Nancy Lurie Marks Family Foundation
  • National Institutes of Health
  • National Institute on Deafness and Other Communication Disorders (DC010290, R01DC010290)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
autism spectrum disorder, biomarkers, inhibition, excitatory-inhibitory imbalance, neural network dynamics, gene expression, protein biomarkers, ASD diagnosis, treatment response monitoring
MeSH terms
Autism Spectrum Disorder, Brain, Humans, Neural Inhibition, Neurons, Biomarkers, GABAergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review